Updated articles of association
02-07-10 kl. 2/7 2010 16:31 | Affitech 0,05 (-44,44%)
Se flere nyheder om Affitech
Release no. 23/2010
Updated articles of association
Contact:
Randi Krogsgaard, Corporate Communications
Tel # +45 2320 1001
About Affitech
Affitech AS is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic
antibody company headquartered in Copenhagen, Denmark with R&D facilities in
Oslo, Norway. The company utilizes a range of proprietary antibody technologies
for the discovery of fully human antibodies for application in oncology,
inflammation and other disease areas. CBAS? (Cell Based Antibody Selection) is
Affitech's premier discovery engine for the isolation of lead
articles of association - unauthorised translation 300610.pdf
Der er endnu ikke skrevet nogen kommentarer til denne artikel.
Skriv en kommentarer til denne artikel:
Send kommentar
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 0,05 |
|---|---|
| ÆNDRING | -0,04 (-44,44%) |
| ÅBEN | 0,08 |
| SIDSTE LUK | 0,09 |
| DEBAT | - |
 |
